Literature DB >> 4006643

Gastric antisecretory activity of arbaprostil as affected by gastric pH.

S B Reele.   

Abstract

Arbaprostil [15(R),15-methyl prostaglandin E2] is inactive. In the presence of acid it is converted to the active 15(S) configuration. The degree of acidity needed for the conversion is not known. We inferred the degree of conversion in vivo in man at different gastric pHs by administering arbaprostil to normal volunteers whose gastric pH was maintained constant at various levels by intragastric titration. A pH-dependent inhibition of gastric acid secretion after stimulation with a peptone meal was observed, with 100 micrograms inhibiting 98% of acid production at pH 2, but only 15% at pH 6. Significant gastric acid inhibition occurred with the gastric pH at, or less than, 5.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006643     DOI: 10.1007/bf01308408

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  The effect of intravenous infusions of prostaglandins E-2 and F-2alpha on human gastric function.

Authors:  A Newman; J P de Moraes-Filho; D Philippakos; J J Misiewicz
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

2.  Gastric emptying in patients with achlorhydria or hyposecretion of hydrochloric acid.

Authors:  L Halvorsen; G Dotevall; A Walan
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

3.  Gastric antisecretory effect of 15(R)-15-menthyl PGE2, methyl ester and of 15(S)-15-methyl ester.

Authors:  A Robert; E W Yankee
Journal:  Proc Soc Exp Biol Med       Date:  1975-04

4.  Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study.

Authors:  G Vantrappen; J Janssens; T Popiela; J Kulig; G N Tytgat; K Huibregtse; R Lambert; J P Pauchard; A Robert
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

5.  The inhibitory effect of 15(R)15 methyl prostaglandin E2 and the interaction with atropine on stimulated gastric acid secretion in man.

Authors:  B Kollberg; C Johansson
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

6.  Effect of 15 (R) 15 methyl prostaglandin E2 on the healing of gastric ulcers: a double-blind endoscopic study.

Authors:  W P Fung; S M Karim
Journal:  Med J Aust       Date:  1976-07-24       Impact factor: 7.738

7.  Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.

Authors:  D A Gilbert; C M Surawicz; F E Silverstein; C R Weinberg; D R Saunders; A D Feld; R L Sanford; D Bergman; P Washington
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

8.  Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion.

Authors:  S M Karim; D C Carter; D Bhana; P A Ganesan
Journal:  Br Med J       Date:  1973-01-20

9.  Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally.

Authors:  A Robert; G Kane; S B Reele
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

10.  Gastrointestinal protection by low-dose oral prostaglandin E2 in rheumatic diseases.

Authors:  B Kollberg; R Nordemar; C Johansson
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

  10 in total
  1 in total

1.  Effect of 15(R)-15-methyl PGE2 (arbaprostil) on duodenal bicarbonate secretion in rat.

Authors:  J Y Li; T Nagata; M Yoshida; N Yagi; K Katoh; T Haramoto; K Itoh; A Iwasaki; Y Matsuo
Journal:  Gastroenterol Jpn       Date:  1989-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.